![](https://investorshub.advfn.com/uicon/719271.png?cb=1717082151)
Wednesday, May 24, 2023 10:07:45 AM
Its a gamble as there is no income for PPCB and there is a lot of payroll going out, but someone said years ago that the payroll is peanuts compared to what big pharma CEO's make.
If the enzyme treatment ever goes into human trials this will take off, but PPCB has been saying they plan on human trials in ~6 months for 6 years at least!
This is why I get in this stock, I dont want to miss the human trials. Ive lost money multiple times, but one update and ill make it all back. When that happens is anyones guess. I won't say 1 year, or 5 years, but I do believe there will be human trials with the treatment and I dont want to miss it!
You can see the Quarterlies, which this is one of the few that submits them on time that I follow, and you will have a decent idea on when dilution starts to occur. I try to stay away from those dates.
Good Luck to You!
Recent PPCB News
- Biopharma on a Tear After Certificate of Grant from Japanese Patent Office • AllPennyStocks.com • 06/25/2024 04:26:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM